explore -WSS

explore

author：comprehensive 2025-10-01 22:16:14 - browse：5182

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Verily hires former Apple Health leader as chief scientific officer

hotspot

WSS

Skip the lead apron during X

Stem cell clinics for heart failure: buyer be wary

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

My superpower is killing ticks

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

STAT wants to know your pick for a great summer read or listen

focus

explore

Wikipedia

Affirmative action in medical school literally saved lives

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

In Memoriam: Notable people who died in 2023

Gilgo Beach: Police identify another victim in serial killing investigation

Apple is now the first public company to be valued at $3 trillion

Hubble vs. James Webb telescope images: See the difference

Affirmative action in medical school literally saved lives

Biden calls for immediate release of Niger's president amid apparent coup

Anesthesiologist group: stop taking Ozempic before surgery

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

hotspot

Use doctors trained outside the U.S. to ease the physician shortage

2 US Navy sailors arrested for allegedly spying for China

Nearly two

Use doctors trained outside the U.S. to ease the physician shortage

Humana, CVS hope to turn members into patients at clinics

Prescription digital therapeutics are key to pharma’s future

Wikipedia

knowledge

hotspot

focus